Glucocorticoid-induced osteoporosis (GIOP) is one of the most common and serious adverse effects associated with glucocorticoid use. This article highlights GIOP pathophysiology, epidemiologic associations, effective treatment, and lifestyle modifications that can reduce fracture risk for long-term glucocorticoid users and additionally emphasizes the importance of early intervention.
Keywords: Fracture risk; Glucocorticoids; Osteoporosis; Prevention.
Copyright © 2016 Elsevier Inc. All rights reserved.